ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $13,077,000 | -8.9% | 323,518 | +29.7% | 0.05% | -5.3% |
| Q2 2015 | $14,351,000 | -9.6% | 249,372 | 0.0% | 0.06% | -12.3% |
| Q1 2015 | $15,878,000 | +37.1% | 249,372 | +32.9% | 0.06% | +41.3% |
| Q4 2014 | $11,585,000 | +69.9% | 187,646 | +6.8% | 0.05% | +58.6% |
| Q3 2014 | $6,820,000 | +12.0% | 175,640 | -0.6% | 0.03% | +16.0% |
| Q2 2014 | $6,090,000 | -23.3% | 176,768 | -3.9% | 0.02% | -28.6% |
| Q1 2014 | $7,945,000 | +14.4% | 183,879 | +5.5% | 0.04% | +12.9% |
| Q4 2013 | $6,944,000 | +11.7% | 174,304 | +5.2% | 0.03% | 0.0% |
| Q3 2013 | $6,218,000 | +77.5% | 165,635 | +27.0% | 0.03% | +63.2% |
| Q2 2013 | $3,504,000 | – | 130,398 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |